VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were up 15.4% on Tuesday . The company traded as high as C$0.15 and last traded at C$0.15. Approximately 103,556 shares changed hands during trading, a decline of 21% from the average daily volume of 131,321 shares. The stock had previously closed at C$0.13.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of -63.20, a current ratio of 0.08 and a quick ratio of 6.67. The business has a fifty day moving average of C$0.11 and a 200 day moving average of C$0.11. The stock has a market cap of C$28.15 million, a PE ratio of -5.00 and a beta of -0.92.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
- Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
- Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
